Episode
Alcon and Lensar Call Off Merger
- Podcast
- Eyewire News: The Podcast
- Published
- Mar 18, 2026
- Duration seconds
- 382
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/eyewire-news-the-podcast-7055536/episodes/alcon-and-lensar-call-off-merger/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/alcon-and-lensar-call-off-merger.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Alcon and Lensar provide a major update to their proposed merger; the latest IOL on Johnson & Johnson’s Tecnis platform receives FDA approval; and the FDA issues another CRL to Aldeyra Therapeutics for its investigational dry eye drug reproxalap. Learn more about your ad choices. Visit megaphone.fm/adchoices